Invenomic Capital Management LP Boosts Stake in Teladoc Health, Inc. $TDOC

Key Points

• Invenomic Capital Management LP has increased its stake in Teladoc Health, Inc. by 36.3%, owning a total of 1,327,128 shares valued at approximately $10.56 million as of the end of the most recent quarter.
• Teladoc Health's earnings report showed a loss of $0.19 per share for the quarter, which was better than the expected loss of $0.27, and revenue of $631.90 million, exceeding estimates.
• The company has a market capitalization of $1.35 billion and a consensus rating of "Hold" from analysts, with a target price averaging around $9.80.

Invenomic Capital Management LP boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 36.3% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,327,128 shares of the health services provider's stock after acquiring an additional 353,478 shares during the period. Invenomic Capital Management LP owned about 0.76% of Teladoc Health worth $10,564,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in TDOC. Chiron Capital Management LLC lifted its position in shares of Teladoc Health by 92.1% in the first quarter. Chiron Capital Management LLC now owns 65,505 shares of the health services provider's stock valued at $521,000 after acquiring an additional 31,400 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Teladoc Health by 40.7% in the first quarter. Canada Pension Plan Investment Board now owns 321,800 shares of the health services provider's stock worth $2,562,000 after acquiring an additional 93,100 shares during the last quarter. State of Wyoming boosted its stake in shares of Teladoc Health by 63.5% in the first quarter. State of Wyoming now owns 52,821 shares of the health services provider's stock worth $420,000 after acquiring an additional 20,520 shares during the last quarter. Trexquant Investment LP boosted its stake in shares of Teladoc Health by 198.9% in the first quarter. Trexquant Investment LP now owns 907,859 shares of the health services provider's stock worth $7,227,000 after acquiring an additional 604,116 shares during the last quarter. Finally, Virtus Advisers LLC acquired a new stake in shares of Teladoc Health in the first quarter worth approximately $348,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Trading Down 2.5%

Shares of TDOC traded down $0.19 during mid-day trading on Wednesday, reaching $7.61. The stock had a trading volume of 2,374,870 shares, compared to its average volume of 6,770,921. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The firm has a market cap of $1.34 billion, a price-to-earnings ratio of -6.41 and a beta of 1.84. The business's fifty day moving average is $7.75 and its 200 day moving average is $7.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same quarter in the previous year, the business earned ($0.38) earnings per share. The company's revenue for the quarter was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analysts Set New Price Targets

TDOC has been the topic of a number of research analyst reports. Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target on the stock. Evercore ISI lifted their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Truist Financial lowered their price target on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday, May 27th. Finally, Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Six analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and a consensus target price of $9.80.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.